News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
16 Sep 2022
byStephen Padilla
Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.
16 Sep 2022







